Inhibition and treatment of Hepatitis B virus and Flavivirus by Helioxanthin and its analogs
US6306899A · kind A · utility
12Cited by
16References
51Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 23, 1999 |
| Grant date | Oct 23, 2001 |
| Priority date | — |
| Expiry date | Aug 23, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to anti-viral drugs such as Helioxanthin and its analogs. The present compounds may be used alone or in combination with other drugs for the treatment of Hepatitis B virus (HBV), Hepatitis C virus (HCV), Yellow Fever, Dengue Virus, Japanese Encephalitis, West Nile virus and related flaviviruses. In addition, compounds according to the present invention can be used to prevent hepatoma secondary to virus infection as well as other infections or disease states which are secondary to the virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.